Log in

AVITA MED LTD/S Stock Forecast, Price & News

+0.38 (+1.58 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $24.43
50-Day Range
MA: $25.06
52-Week Range
Now: $24.43
Volume48,599 shs
Average Volume106,684 shs
Market Capitalization$524.46 million
P/E RatioN/A
Dividend YieldN/A
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company is based in Valencia, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.34 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:RCEL



Sales & Book Value

Annual Sales$14.26 million
Book Value$3.37 per share



Market Cap$524.46 million
Next Earnings DateN/A
OptionableNot Optionable
+0.38 (+1.58 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RCEL News and Ratings via Email

Sign-up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

AVITA MED LTD/S (NASDAQ:RCEL) Frequently Asked Questions

How has AVITA MED LTD/S's stock been impacted by Coronavirus (COVID-19)?

AVITA MED LTD/S's stock was trading at $6.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RCEL shares have increased by 301.8% and is now trading at $24.43.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of AVITA MED LTD/S?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AVITA MED LTD/S in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for AVITA MED LTD/S

What guidance has AVITA MED LTD/S issued on next quarter's earnings?

AVITA MED LTD/S updated its fourth quarter 2020 After-Hours earnings guidance on Thursday, July, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.88-3.88 million.

What price target have analysts set for RCEL?

5 brokerages have issued twelve-month price targets for AVITA MED LTD/S's shares. Their forecasts range from $12.00 to $45.00. On average, they expect AVITA MED LTD/S's share price to reach $36.40 in the next twelve months. This suggests a possible upside of 49.0% from the stock's current price.
View analysts' price targets for AVITA MED LTD/S

Are investors shorting AVITA MED LTD/S?

AVITA MED LTD/S saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 121,900 shares, a decline of 37.8% from the August 31st total of 195,900 shares. Based on an average daily trading volume, of 123,000 shares, the short-interest ratio is presently 1.0 days. Approximately 0.1% of the company's shares are sold short.
View AVITA MED LTD/S's Short Interest

Who are some of AVITA MED LTD/S's key competitors?

What other stocks do shareholders of AVITA MED LTD/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AVITA MED LTD/S investors own include NVIDIA (NVDA), Square (SQ), Micron Technology (MU), Twilio (TWLO), AbbVie (ABBV), Alibaba Group (BABA), Inovio Pharmaceuticals (INO), Netflix (NFLX), Paypal (PYPL) and Roku (ROKU).

What is AVITA MED LTD/S's stock symbol?

AVITA MED LTD/S trades on the NASDAQ under the ticker symbol "RCEL."

Who are AVITA MED LTD/S's major shareholders?

AVITA MED LTD/S's stock is owned by a number of institutional and retail investors. Top institutional investors include MCF Advisors LLC (0.07%), Jane Street Group LLC (0.07%), Financial Consulate Inc. (0.05%), Advisors Asset Management Inc. (0.02%), Steward Partners Investment Advisory LLC (0.02%) and Bank of America Corp DE (0.01%). Company insiders that own AVITA MED LTD/S stock include David Mcintyre and Michael S Perry.
View institutional ownership trends for AVITA MED LTD/S

Which major investors are selling AVITA MED LTD/S stock?

RCEL stock was sold by a variety of institutional investors in the last quarter, including Financial Consulate Inc., Steward Partners Investment Advisory LLC, Advisor Group Holdings Inc., PNC Financial Services Group Inc., Larson Financial Group LLC, Bank of America Corp DE, and MCF Advisors LLC.
View insider buying and selling activity for AVITA MED LTD/S

Which major investors are buying AVITA MED LTD/S stock?

RCEL stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC, and Advisors Asset Management Inc..
View insider buying and selling activity for AVITA MED LTD/S

How do I buy shares of AVITA MED LTD/S?

Shares of RCEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AVITA MED LTD/S's stock price today?

One share of RCEL stock can currently be purchased for approximately $24.43.

How big of a company is AVITA MED LTD/S?

AVITA MED LTD/S has a market capitalization of $524.46 million and generates $14.26 million in revenue each year. The company earns $-42,030,000.00 in net income (profit) each year or ($2.07) on an earnings per share basis.

What is AVITA MED LTD/S's official website?

The official website for AVITA MED LTD/S is www.avitamedical.com.

How can I contact AVITA MED LTD/S?

AVITA MED LTD/S's mailing address is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. The company can be reached via phone at 661-367-9170 or via email at [email protected]

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.